Thursday, Sep 21, 2023
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Education Today
    • Reviews
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | Business | Glenmark Pharma Gets Usfda Nod For Icatibant Injection

Glenmark Pharma gets USFDA nod for Icatibant Injection

Indicated for the treatment of acute attacks of hereditary angioedema (HAE).

By PTI
Published Date - 11:35 AM, Mon - 24 May 21
Glenmark Pharma gets USFDA nod for Icatibant Injection
Representational Image.
whatsapp facebook twitter telegram

New Delhi: Drug major Glenmark Pharma on Monday said it has received final approval from the US health regulator for Icatibant Injection, indicated for the treatment of acute attacks of hereditary angioedema (HAE).

Hereditary angioedema (HAE) is a disorder that results in recurrent attacks of severe swelling.
The approved product is a generic version of Firazyr Injection of Shire Human Genetic Therapies, Inc.

Glenmark Pharmaceuticals has received final approval by the United States Food and Drug Administration (USFDA) for Icatibant Injection, 30 mg/3 mL (10 mg/mL) single-dose prefilled syringe, the company said in a regulatory filing.

Quoting IQVIA sales data for the 12 months ending March 2021, Glenmark said Firazyr Injection, 30 mg/3 mL single-dose prefilled syringe market achieved annual sales of approximately USD 223.4 million.

The drug firm said its current portfolio consists of 172 products authorised for distribution in the US marketplace and 44 abbreviated new drug applications are pending approval with the USFDA.

Shares of Glenmark Pharma were trading 1.26 per cent higher at Rs 615 apiece.

Telangana Today Whatsapp
  • Follow Us :
  • Tags
  • Glenmark Pharma
  • Hereditary angioedema (HAE)
  • Icatibant Injection
  • United States Food and Drug Administration (USFDA)

Related News

  • Glenmark Pharma to sell 75% stake in life sciences unit to Nirma for Rs 5,651 cr

    Glenmark Pharma to sell 75% stake in life sciences unit to Nirma for Rs 5,651 cr

  • Glenmark Pharma to use IFC’s $40 mn loan for debt refinance and capex

    Glenmark Pharma to use IFC’s $40 mn loan for debt refinance and capex

Latest News

  • Four-day annual Ladakh festival begins in Leh

    2 mins ago
  • Hyderabad She teams nab 55 persons for stalking, harassing women at Khairatabad Ganesh pandal

    4 mins ago
  • Devi Prasad’s poetry collection ‘Blissful Rambles’ launched

    8 mins ago
  • Why Indian batters don’t bowl? Blame it on five-fielder rule: Dravid

    10 mins ago
  • Mumbai: Two persons get 10 years in jail in 2015 fake Indian currency note case

    14 mins ago
  • Former Ramayampet MLA RS Vasu Reddy passes away

    20 mins ago
  • Queen of hearts: Sara Ali Khan wishes Kareena Kapoor Khan on her birthday

    24 mins ago
  • NCDC gives in-principle nod for TS Fisheries Development Scheme Phase II

    10 mins ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam